Company Profile
Shanghai Kehua Bio-Engineering researches, develops, produces, and sells reagents and instruments and services in China and globally. The company offers immunoassay and clinical chemistry systems, HIV colloid gold test kits, ELISA HBV test kits, renal disease management solution, and automated comprehensive solutions for nucleic acid blood screening automatic modular and clinical chemistry analyzers and clinical chemistry reagents test menu.
Its portfolio also includes automatic chemiluminescence immunoassay analyzers and CLIA reagents test menu, automatic ELISA microplate readers, ELISA microplate washers, and enzyme-linked immunoassay reagents, and diagnostics kit for HIV and SARS-CoV-2 IgM/IgG antibody, HIV I/II Ab rapid tests, diagnostic kit for Hepatitis B surface antigen and Hepatitis C virus antibody, and diagnostic kit for antibody to T. Palladium.
Additionally, it offers molecular diagnostics solutions, including fully automated nucleic acid blood screening laboratory solution and nucleic acid testing and detection kits. Its portfolio also includes automatic multifunctional veterinary analyzer, and mass spectrometry.
It exports its products, as well as instrument products, including biochemical diagnostics, immunological diagnostics, molecular diagnostics, point-of-care testing (POCT), and mass spectrometry, advancing towards automation, digitization, and intelligence.
The company serves healthcare institutions, blood centers, disease control and prevention centers, and research organizations. Its products are used in clinical diagnostics, blood screening, public health, food safety, and scientific research applications. Founded in 1981, the company is headquartered in Shanghai, China.